References
- Higuchi S., Sasaki H. Pharmacokinetic studies on nicardipine hydrochloride, a new vasodilator, after repeated administration to rats, dogs and humans. Xenobiotica 1980; 10(12)897–903
- Graham D. J. M., Dow R. J., Freedman D., Mroszczak E. Pharmacokinetics of nicardipine following oral and intravenous administration in man, Postgrad. Med. J. Suppl. 1984; 60(4)7–10
- Webster J., Petrie J. C., Jeffers T. A., Roy-Chaudhury P., Crichton W., Witte K., Jamieson M., Macdonald F. C., Beard M., Dow R. J., Murray G. R. Nicardipine sustained release in hypertension. Br. J. Clin. Pharmacol. Oct., 1991; 32: 433–439
- Webster J., Witte K., Rawles J., Petrie J. C., Jeffers T. A., Macdonald C., Gough K. Evaluation of a long acting formulation of nicardipine in hypertension by clinic and home recorded blood pressures and Doppler aortavelography. Br. J. Clin. Pharmacol. May, 1989; 27: 563–568
- Giunchedi P., Conte U., Maggi L., La Manna A. Hydrophilic matrices for the extended release of a model drug exhibiting pH-dependent solubility. Int. J. Pharm. 1992; 85(1–3)141–147
- Hasegawa A., Hiroshi N., Sugimoto I. Application of solid dispersions of nifedipine with enteric coating agent to prepare a sustained-release dosage form. Chem. Pharm. Bull. 1985; 33(4)1615–1619
- Hasegawa A., Kawamura R., Nakagawa H., Sugimoto I. Application of solid dispersions with enteric coating agents to overcome some pharmaceutical problems. Chem. Pharm. Bull. 1986; 34(5)2183–2190
- Follonier N., Doelker E. Biopharmaceutical comparison of oral multi-component and single-unit sustained release dosage forms. S.T.P. Pharma Sci. 1992; 2(2)141–158
- Kim C.-K., Kim M.-J., Oh K.-H. Preparation and evaluation of controlled release microspheres of terbutaline sulfate. Int. J. Pharm. 1994; 106(3)213–219
- Pongpaibul Y., Price J. C., Whitworth C. W. Preparation and evaluation of controlled release indomethacine microspheres. Drug Dev. Ind. Pharm. 1984; 10(10)1597–1616
- Wagner G., Ling T. L., Mroszczak E. J., Freedman D., Wu A., Huang B., Massey I. J., Roe R. R. Single intravenous dose and steady-state oral dose pharmacokinetics of nicardipine in healthy subjects. Biopharm. Drug Dispos. Mar-Apr, 1987; 8: 133–148
- Kawata M., Nakamura M., Goto S., Aoyama T. Preparation and dissolution patterns of Eudragit RS microcapsules containing ketoprofen. Chem. Pharm. Bull. 1986; 34(6)2618–2623
- Kawashima Y., Iwamoto T., Niwa T., Takeuchi H., Hino T. Role of the solvent-diffusion-rate modifier in a new emulsion solvent-diffusion method for preparation of ketoprofen microspheres. J. Microencapsulation 1993; 10(3)329–340
- Robert C. C. R., Buri P. A., Peppas N. A. Influence of the drug solubility and dissolution medium on the release from poly(2-hydroxyefhyl methacrylate) microspheres. J. Controlled Release Sep, 1987; 5: 151–157
- Gehrke S. H., Lee P. I. Hydrogels for drug delivery systems. Specialized Drug Delivery Systems—Manufacturing and Production Technology, P. Tyle. Marcel Dekker, Inc., New York 1990; 333–392
- Wagner J. G. Biopharmaceutics and Relevant Pharmacokinetics. Drug Intelligence Publications, Illinois 1971; 115–118
- Eudragit Data Sheets, Industrial Products Division. Röhm Pharma GmbH, WeiterstadtGermany
- Yiiksel N., Baykara T. Preparation and evaluation of controlled release microspheres containing nicardipine hydrochloride. Int. J. Pharm. Adv. 1996; 1(4)398–407
- Yüksel N., Tinçer T., Baykara T. The interaction between nicardipine hydrochloride and polymeric microspheres for a controlled release system. Int. J. Pharm. 1996; 140(2)145–154